Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emmessar Biotech & Nutrition has informed that a meeting of Board of Directors of the Company, will be held on Friday, May 21, 2021, to consider and approve the Audited Financial Results of the Company, for the Quarter and Year ended March 31, 2021. Further, Trading Window for dealing in Securities of the Company shall remain closed till expiry of 48 hours after declaration of Audited Financial Results, as intimated through its intimation letter dated 31th March, 2021.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1464.85 |
Dr. Reddys Lab | 5955.65 |
Cipla | 1477.15 |
Zydus Lifesciences | 1050.35 |
Lupin | 1603.55 |
View more.. |